Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Proinflammatory Cytokines could help improve the diagnosis and treatment of prostate cancer

03.12.2008
Researchers from the University of Alcalá (UAH) have concluded that there could be a link between the high expression of proinflammatory Cytokines and high levels of prostate specific antigen (PSA) with the progression of prostate cancer.

Prostate cancer is one of the most common tumours affecting the male population, and a digital rectal examination is the main method for an early detection.

Several years ago, prostate specific antigen (PSA) levels where introduced as a diagnostic test and follow-up of the disease, but there are alternative situations such as manipulation of the prostate gland in a biopsy or a rectal exam, and other benign diseases like hyperplasia, that cause a temporary elevation of PSA levels leading to false positives.

The opposite is also true, since normal levels of PSA have been measured in patients suffering the tumoural pathology. Therefore the prostate specific antigen is not an indication of the degree of development of the disease.

The researchers of the department of genetics and cell biology at the University of Alcalá decided to look for new prognostic markers that together with the PSA would increase the diagnostic specificity of the disease. The molecules selected for the study where Proinflammatory Cytokines that already play an important role in the development of the cancer. Their work consisted in relating the expression of different Proinflammatory Cytokines, Interleuquines 1 & 6 and the necrosis factor-alpha (TFN-a), with the levels of prostate specific antigen (PSA) in blood serum, both for normal patients (without tumoural pathology), as well as for pathologic conditions (hyperplasia and cancer), while also relating them to their role in tumour progression as stated by Mar Royuela.

To achieve this, they studied prostate samples of healthy patients with benign hyperplasia and with prostate cancer in collaboration with the researchers from the Université du 7 Novembre à Carthage of Tunisia. The results of the study, published in the journal Cancer detection and prevention, indicate that there could be a link between high expression of Proinflammatory Cytokines IL-1, TNF- a and IL-6 and high seric levels of PSA with the progression of the cancer. It is possible that a better understanding of the biological mechanism of such an association could lead to a therapeutic target in patients suffering from a prostate pathology, as the professor of Alcalá University explains.

The research group for solid tumour cellular biology and tissue regeneration at the UAH has dedicated over 10 years to the study of histology and cellular biology of the healthy and anomalous human prostate; work that was complemented by the study of breast cancer. Their line of thinking focuses on the intermediaries in the different transduction paths initiated by the TNF-alpha/ IL-1 that activate different transcription factors involved in cellular proliferation. “Cancer is a complex process that involves many factors. Only by knowing most of them we will be able to find an effective therapy”, Professor Royuela states. “In order to achieve this objective the investigation must continue. In our case, we propose to study one of bifurcations in the transcription routes which lead to the activation of NF-kB. In the future, we will complement our research with the study of the link between these paths and the family of proteins that inhibits apoptosis (cell death) and which acts mainly on caspases”, concludes the researcher of Alcalá University.

Oficina Información Científica | alfa
Further information:
http://www.uah.es

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>